Statements of Operations-Additional Information (Tables)

9 Months Ended

Mar. 31, 2025

Statements of Operations-Additional Information

Schedule of revenues disaggregated by major product category and geographic region

Net Sales by Product Type

	Three Months				Nine Months
For the Periods Ended March 31	2025		2024		2025		2024
Animal Health
MFAs and other	$	181,645	$	108,216	$	439,827	$	304,261
Nutritional specialties		43,350		40,194		131,908		121,840
Vaccines		33,382		32,923		98,583		88,866
Total Animal Health	$	258,377	$	181,333	$	670,318	$	514,967
Mineral Nutrition		66,774		64,228		189,086		181,601
Performance Products		22,674		17,662		58,114		47,947
Total	$	347,825	$	263,223	$	917,518	$	744,515

Net Sales by Region

	Three Months				Nine Months
For the Periods Ended March 31	2025		2024		2025		2024
United States	$	209,940	$	159,314	$	537,930	$	431,083
Latin America and Canada		70,753		53,653		214,578		177,539
Europe, Middle East and Africa		38,910		33,175		102,624		89,572
Asia Pacific		28,222		17,081		62,386		46,321
Total	$	347,825	$	263,223	$	917,518	$	744,515

Schedule of interest expense, net

	Three Months				Nine Months
For the Periods Ended March 31	2025		2024		2025		2024
Interest expense, net
Credit Facilities	$	9,029	$	5,127	$	24,393	$	15,421
2022 Term Loan		—		215		12		648
Amortization of debt issuance costs		572		260		1,443		780
Refinancing expense		—		—		1,960		—
Other		52		43		388		164
Interest expense		9,653		5,645		28,196		17,013
Interest income		(298)		(1,070)		(2,204)		(3,215)
	$	9,355	$	4,575	$	25,992	$	13,798

Schedule of depreciation and amortization

	Three Months				Nine Months
For the Periods Ended March 31	2025		2024		2025		2024
Depreciation and amortization
Depreciation of property, plant and equipment	$	10,897	$	6,770	$	27,048	$	19,638
Amortization of intangible assets		1,719		2,426		6,146		7,339
	$	12,616	$	9,196	$	33,194	$	26,977